Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-20

Clinical Trial Update: Vinorelbine for Children With Progressive or Recurrent Low-grade Gliomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vinorelbine for children with progressive or recurrent low-grade gliomas has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vinorelbine (Vinorelbine)

Snippet

Sponsor: Eugene Hwang | Conditions: Low-grade Glioma | Phase 2 | Status: COMPLETED | Results posted: 2019-05-20